Oral lichenoid lesions in association with immunotherapies: a report of two cases and a review of published work

Key Points

• Oral lichenoid lesions were identified in patients undergoing immunotherapies, highlighting a rare side effect.
• The cases show the importance of recognizing oral adverse events tied to specific drug regimens.
• Case report detailing two instances of oral lichenoid lesions with immunotherapy involvement indicates a significant correlation.
• Reporting and management improvements are necessary to address these oral side effects and ensure patient safety.